Gold BG |
FK506 and the role of the immunophilin FKBP-52 in nerve regeneration. |
1999 |
Drug Metab. Rev. |
pmid:10461545
|
Morris-Stiff GJ et al. |
Conversion from cyclosporin (Neoral) to tacrolimus (Prograf) in renal allograft recipients with chronic graft nephropathy: results of an observational study. |
1999 |
Transpl. Int. |
pmid:10460877
|
Burke GA et al. |
The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy. |
1999 |
Pediatr. Nephrol. |
pmid:10460501
|
Drachenberg CB et al. |
Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. |
1999 |
Transplantation |
pmid:10459544
|
Van Gelder RN and Kaplan HJ |
Immunosuppression in uveitis therapy. |
1999 |
Springer Semin. Immunopathol. |
pmid:10457590
|
Hachida M et al. |
Combined use of deoxyspergualin and FK 506 for temporary circulatory assist. |
1999 |
Transplant. Proc. |
pmid:10455968
|
Kobashigawa JA |
Postoperative management following heart transplantation. |
1999 |
Transplant. Proc. |
pmid:10455966
|
Jiang H and Kobayashi M |
Differences between cyclosporin A and tacrolimus in organ transplantation. |
1999 |
Transplant. Proc. |
pmid:10455942
|
Miura S et al. |
The beneficial effects of FK 506 on living-related renal transplantation in presensitized recipients. |
1999 |
Transplant. Proc. |
pmid:10455940
|
Jones JW et al. |
Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy. |
1999 |
Surgery |
pmid:10455910
|
Penson MG et al. |
Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients. |
1999 |
J. Heart Lung Transplant. |
pmid:10452348
|
Armstrong HM et al. |
Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicity. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10450987
|
Goulet MT et al. |
C32-O-phenalkyl ether derivatives of the immunosuppressant ascomycin: a tether length study. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10450986
|
Volbracht C et al. |
ATP controls neuronal apoptosis triggered by microtubule breakdown or potassium deprivation. |
1999 |
Mol. Med. |
pmid:10449809
|
Uchiyama H et al. |
Approach to withdrawal from tacrolimus in a fully allogeneic murine skin graft model. |
1999 |
Immunology |
pmid:10447745
|
Kur F et al. |
Tacrolimus (FK506) as primary immunosuppressant after lung transplantation. |
1999 |
Thorac Cardiovasc Surg |
pmid:10443520
|
Magee CC et al. |
Nocardial infection in a renal transplant recipient on tacrolimus and mycophenolate mofetil. |
1999 |
Clin. Nephrol. |
pmid:10442495
|
Moxey-Mims MM |
Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506) |
1999 |
Transplantation |
pmid:10440413
|
Sheikh AM et al. |
Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. |
1999 |
Transplantation |
pmid:10440408
|
Tsuji Y et al. |
Effects of cyclosporin A, FK506 and steroid hormones on hair growth. |
1999 |
Exp. Dermatol. |
pmid:10439282
|
Harikrishnan P and Harden PN |
Tacrolimus can resolve cyclosporin-induced gingival hyperplasia. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10435907
|
Briggs WA et al. |
Lymphocyte suppression by rolipram with other immunosuppressive drugs. |
1999 |
J Clin Pharmacol |
pmid:10434230
|
Shinkura N et al. |
Autoantibodies to FK506 binding protein 12 (FKBP12) in autoimmune diseases. |
1999 |
Autoimmunity |
pmid:10433096
|
Pollock R and Rivera VM |
Regulation of gene expression with synthetic dimerizers. |
1999 |
Meth. Enzymol. |
pmid:10432459
|
Levy GA |
Neoral/cyclosporine-based immunosuppression. |
1999 |
Liver Transpl Surg |
pmid:10431016
|
Soccal PM et al. |
Improvement of drug-induced chronic renal failure in lung transplantation. |
1999 |
Transplantation |
pmid:10428288
|
Reichenspurner H et al. |
Optimization of the immunosuppressive protocol after lung transplantation. |
1999 |
Transplantation |
pmid:10428269
|
Kahan BD |
An immunosuppressive triumvirate to minimize renal injuries associated with calcineurin antagonist therapy. |
1999 |
Transplantation |
pmid:10428260
|
Jamieson NV |
Adult small intestinal transplantation in Europe. |
1999 Apr-Jun |
Acta Gastroenterol. Belg. |
pmid:10427790
|
Pirenne J |
Contribution of large animal models to the development of clinical intestinal transplantation. |
1999 Apr-Jun |
Acta Gastroenterol. Belg. |
pmid:10427786
|
Kato K et al. |
Modulation of long-term potentiation induction in the hippocampus by N-methyl-D-aspartate-mediated presynaptic inhibition. |
1999 |
Neuroscience |
pmid:10426482
|
Becker JW et al. |
32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein. |
1999 |
J. Med. Chem. |
pmid:10425089
|
Dunn SE et al. |
Calcineurin is required for skeletal muscle hypertrophy. |
1999 |
J. Biol. Chem. |
pmid:10419511
|
Dalvit C et al. |
Use of organic solvents and small molecules for locating binding sites on proteins in solutions. |
1999 |
J. Biomol. NMR |
pmid:10419292
|
Remitz A et al. |
Tacrolimus ointment improves psoriasis in a microplaque assay. |
1999 |
Br. J. Dermatol. |
pmid:10417522
|
Mrowietz U |
Macrolide immunosuppressants. |
1999 Jul-Aug |
Eur J Dermatol |
pmid:10417434
|
Min DI et al. |
Sudden hearing loss associated with tacrolimus in a kidney-pancreas allograft recipient. |
1999 |
Pharmacotherapy |
pmid:10417040
|
Finn WF |
FK506 nephrotoxicity. |
1999 May-Jul |
Ren Fail |
pmid:10416209
|
Kuroda S et al. |
The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats. |
1999 |
Brain Res. |
pmid:10415369
|
Bavetta S et al. |
The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. |
1999 |
Exp. Neurol. |
pmid:10415144
|
Przepiorka D et al. |
Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation. |
1999 |
Bone Marrow Transplant. |
pmid:10414918
|
Varghese Z et al. |
Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients. |
1999 |
Kidney Int. Suppl. |
pmid:10412758
|
Muegge I et al. |
Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein. |
1999 |
J. Med. Chem. |
pmid:10411471
|
Rhew JH et al. |
Induction of fibronectin gene expression by inhibitors of protein phosphatase type 2B in normal and transformed fibroblasts. |
1999 |
Exp. Mol. Med. |
pmid:10410305
|
Hebert MF and Lam AY |
Diltiazem increases tacrolimus concentrations. |
1999 |
Ann Pharmacother |
pmid:10410178
|
Kaibori M et al. |
Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. |
1999 |
J. Hepatol. |
pmid:10406194
|
Banerjee C et al. |
Ca2+ and calmodulin-dependent protein phosphatase from Leishmania donovani. |
1999 |
Parasitology |
pmid:10406035
|
Timmermann W et al. |
Videomicroscopic imaging of graft mucosa for monitoring immunosuppressive therapy after small intestinal transplantation in rats. |
1999 |
Transplantation |
pmid:10401762
|
Tada H et al. |
Role of diltiazem on tacrolimus pharmacokinetics in tacrolimus-induced nephrotoxic rats. |
1999 |
Pharmacol. Toxicol. |
pmid:10401724
|
Katayama Y |
[Current tendency in treatment for acute ischemic stroke]. |
1999 |
Nippon Ika Daigaku Zasshi |
pmid:10401232
|
Haas M et al. |
Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. |
1999 |
Am. J. Kidney Dis. |
pmid:10401019
|
Gold BG et al. |
Efficacy of delayed or discontinuous FK506 administrations on nerve regeneration in the rat sciatic nerve crush model: lack of evidence for a conditioning lesion-like effect. |
1999 |
Neurosci. Lett. |
pmid:10400242
|
Magee CC et al. |
Immunosuppressive agents in organ transplantation. |
1999 |
Hosp Med |
pmid:10396414
|
Kochi S et al. |
Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells. |
1999 |
Eur. J. Pharmacol. |
pmid:10395024
|
Horowitz MM et al. |
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. |
1999 |
Biol. Blood Marrow Transplant. |
pmid:10392964
|
Hasselder AS |
The nursing management of a patient receiving Prograf as a primary immunosuppressive agent. |
1998 Apr-Jun |
EDTNA ERCA J |
pmid:10392057
|
Liang H et al. |
Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. |
1999 |
J. Biol. Chem. |
pmid:10391929
|
Gerhardt U et al. |
Blood pressure control in kidney transplant recipients: influence of immunosuppression. |
1999 |
J Auton Pharmacol |
pmid:10385269
|
Squadrito F et al. |
Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock. |
1999 |
Br. J. Pharmacol. |
pmid:10385251
|
Leung W et al. |
Long-term complete remission and immune tolerance after intensive chemotherapy for lymphoproliferative disorders complicating liver transplant. |
1999 |
Transplantation |
pmid:10385092
|
Koski GK et al. |
Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. |
1999 |
J. Immunol. |
pmid:10384103
|
Henry ML |
Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles. |
1999 |
Clin Transplant |
pmid:10383101
|
Higgins RM et al. |
Conversion between cyclosporin and tacrolimus--30-fold dose prediction. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10383044
|
Cox KL et al. |
Paediatric liver transplantation: indications, timing and medical complications. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10382641
|
Lieberman DN and Mody I |
Properties of single NMDA receptor channels in human dentate gyrus granule cells. |
1999 |
J. Physiol. (Lond.) |
pmid:10373689
|
Kirk AD et al. |
Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. |
1999 |
Nat. Med. |
pmid:10371508
|
Matzinger P |
Graft tolerance: a duel of two signals. |
1999 |
Nat. Med. |
pmid:10371494
|
Przepiorka D et al. |
Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation. |
1999 |
Biol. Blood Marrow Transplant. |
pmid:10371361
|
Ito F et al. |
FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9. |
1999 |
Arch. Dermatol. Res. |
pmid:10367710
|
Onsager DR et al. |
Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients. |
1999 |
J. Heart Lung Transplant. |
pmid:10363689
|
Venz S et al. |
Contribution of color and power Doppler sonography to the differential diagnosis of acute and chronic rejection, and tacrolimus nephrotoxicity in renal allografts. |
1999 |
Transpl. Int. |
pmid:10363595
|
Jiang H et al. |
Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival. |
1999 |
Transpl. Int. |
pmid:10363590
|
Kanoh S et al. |
Effect of FK506 on ATP-induced intracellular calcium oscillations in cow tracheal epithelium. |
1999 |
Am. J. Physiol. |
pmid:10362712
|
Gummert JF et al. |
Newer immunosuppressive drugs: a review. |
1999 |
J. Am. Soc. Nephrol. |
pmid:10361877
|
Johnson KL and Lawen A |
Rapamycin inhibits didemnin B-induced apoptosis in human HL-60 cells: evidence for the possible involvement of FK506-binding protein 25. |
1999 |
Immunol. Cell Biol. |
pmid:10361256
|
Doolabh VB and Mackinnon SE |
FK506 accelerates functional recovery following nerve grafting in a rat model. |
1999 |
Plast. Reconstr. Surg. |
pmid:10359255
|
Cao S et al. |
Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. |
1999 |
Pediatr Transplant |
pmid:10359027
|
Cheng HH et al. |
Oligomerization state influences the degradation rate of 3-hydroxy-3-methylglutaryl-CoA reductase. |
1999 |
J. Biol. Chem. |
pmid:10358074
|
Muramatsu K et al. |
Limb allotransplantation in rats: combined immunosuppression by FK-506 and 15-deoxyspergualin. |
1999 |
J Hand Surg Am |
pmid:10357540
|
Toung TJ et al. |
Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats. |
1999 |
Stroke |
pmid:10356112
|
Yang J et al. |
Sjögren's syndrome in mice carrying the Ipr(cg) gene and the therapeutic efficacy of an immunosuppressive agent FK506. |
1999 |
Pathol. Int. |
pmid:10355966
|
Zarifian A et al. |
Cyclosporine-associated thrombotic microangiopathy in renal allografts. |
1999 |
Kidney Int. |
pmid:10354295
|
Murata M et al. |
A new preconditioning regimen with melphalan, busulphan and total body irradiation followed by low-dose immunosuppressant in allogeneic haemopoietic stem cell transplantation. |
1999 |
Br. J. Haematol. |
pmid:10354150
|
Möller A et al. |
The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects. |
1999 |
Drug Metab. Dispos. |
pmid:10348790
|
Araki T et al. |
Increases in [3H]FK-506 and [3H]L-N(G)-nitro-arginine binding in the rat brain after nigrostriatal dopaminergic denervation. |
1999 |
Metab Brain Dis |
pmid:10348311
|
Oddis CV et al. |
Tacrolimus in refractory polymyositis with interstitial lung disease. |
1999 |
Lancet |
pmid:10347992
|
Siemann G et al. |
Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context. |
1999 |
Mol. Pharmacol. |
pmid:10347253
|
Boehringer M et al. |
Kaposi's sarcoma after renal transplantation: treatment with liposomal doxorubicin. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10344407
|
|
Tacrolimus in the prevention of graft rejection: new indication. Helpful alternative to ciclosporin. |
1998 |
Prescrire Int |
pmid:10342948
|
Dresske B et al. |
WOFIE augments the immunosuppressive potency of FK-506. Window of opportunity for immunological engagement. |
1998 |
Transpl. Immunol. |
pmid:10342738
|
Khanna A et al. |
Impact of Flt-3 ligand on donor-derived antigen presenting cells and alloimmune reactivity in heart graft recipients given adjuvant donor bone marrow. |
1998 |
Transpl. Immunol. |
pmid:10342736
|
Moffatt SD et al. |
Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model. |
1999 |
Transplantation |
pmid:10342309
|
Uchio E et al. |
Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease. |
1999 Mar-Apr |
Clin. Exp. Rheumatol. |
pmid:10342043
|
Ruddy SB et al. |
Design and characterization of a surfactant-enriched tablet formulation for oral delivery of a poorly water-soluble immunosuppressive agent. |
1999 |
Int J Pharm |
pmid:10341307
|
Ma D and Carlow CK |
Molecular characterization of FKBP13 from filarial parasites. |
1999 |
Mol. Biochem. Parasitol. |
pmid:10340490
|
Conboy IM et al. |
Calcineurin and vacuolar-type H+-ATPase modulate macrophage effector functions. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10339586
|
Ferrand-Drake M et al. |
Mitochondrial permeability transition induced DNA-fragmentation in the rat hippocampus following hypoglycemia. |
1999 |
Neuroscience |
pmid:10338300
|
Steg RE et al. |
Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. |
1999 |
Bone Marrow Transplant. |
pmid:10338054
|
Gold BG et al. |
Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10336507
|
Shirbacheh MV et al. |
Pharmacokinetics of intra-arterial delivery of tacrolimus to vascularly isolated rabbit forelimb. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10336506
|